West Pharmaceutical Services INC Form 4 insider transactions

Silji Abraham, SVP and Chief Technology Officer of West Pharmaceutical Services, reports the acquisition and disposal of common stock and restricted stock units on October 29, 2024.

Charles Witherspoon, VP & Treasurer of West Pharmaceutical Services, reports the exercise of stock options and subsequent sale of shares on August 19, 2024.

Director Thomas Hofmann reported the sale of 617 shares of West Pharmaceutical Services Inc. common stock at a price of $365.92 per share on May 10, 2024.

Eric Mark Green, President, CEO, and Board Chair of West Pharmaceutical Services, executed stock options and sold shares under a pre-arranged Rule 10b5-1 trading plan.

Eric Mark Green, President, CEO, and Board Chair of West Pharmaceutical Services, executed stock options and sold shares of common stock under a pre-arranged 10b5-1 trading plan.

Silji Abraham, SVP and Chief Technology Officer of West Pharmaceutical Services, reported selling 1,800 shares of common stock at a price of $330.78 on June 12, 2024.

Eric Mark Green, President, CEO, and Board Chair of West Pharmaceutical Services, executed stock options and sold shares under a pre-arranged Rule 10b5-1 trading plan.

Director Paolo Pucci reports changes in beneficial ownership of West Pharmaceutical Services Inc. stock, including acquisition of restricted stock units and disposal of shares.

Director Douglas A. Michels acquired 564 shares of West Pharmaceutical Services Inc. common stock on April 23, 2024.

Director Lai Goldman Myla acquired 564 shares of West Pharmaceutical Services Inc. common stock on April 23, 2024.

Director Stephen H. Lockhart acquired 564 shares of West Pharmaceutical Services Inc. common stock on April 23, 2024.

Director Deborah L. Keller acquired 564 shares of West Pharmaceutical Services Inc. common stock on April 23, 2024.

Director Molly Joseph acquired 564 shares of West Pharmaceutical Services Inc. common stock on April 23, 2024.

Director Robert F. Friel acquired 564 shares of West Pharmaceutical Services Inc. common stock on April 23, 2024.

Director William F. Feehery acquired 564 shares of West Pharmaceutical Services Inc. common stock on April 23, 2024.

Mark A. Buthman, a director at West Pharmaceutical Services, acquired 564 shares of common stock on April 23, 2024.

Director Thomas W. Hofmann acquired 564 shares of West Pharmaceutical Services Inc. common stock on April 23, 2024.

Chad Winters, VP and Chief Accounting Officer of West Pharmaceutical Services, reports the acquisition and disposal of company stock and stock options on March 11, 2024.

Charles Witherspoon, VP & Treasurer of West Pharmaceutical Services, executed stock option exercises and sales on February 28, 2024.

Eric Mark Green, President, CEO, and Board Chair of West Pharmaceutical Services, executed stock options and sold shares under a pre-arranged Rule 10b5-1 trading plan.

Silji Abraham, SVP and Chief Technology Officer of West Pharmaceutical Services, exercised stock options and sold shares on February 23, 2024.